Clinical trial · Phase 4

Psoriasis

Guselkumab, subcutaneous

Dr Aayush Gupta is the principal investigator at Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune for a phase 4 study of guselkumab, subcutaneous in psoriasis, sponsored by Johnson & Johnson. Status: opens November 2026.

Phase
Phase 4
Sponsor
Johnson & Johnson
Status
Opening this autumn: Opens November 2026
Principal investigator
Dr Aayush Gupta
Site
Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune
Condition
Psoriasis

Official title

A Phase IV, Multicenter, Non-comparative, Open-Label Study Evaluating the Safety and Efficacy of Guselkumab Administered Subcutaneously in the Treatment of Indian Patients with Psoriasis (CNTO1959PSO4039)

Other trials